Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs)

1 意见
administrator
administrator
07/08/23

Session 2 of IASNM Radiant Flashpoints Educational Web-Series.
Speaker: David L. Bushnell, MD,
Professor of Radiology, Division of Nuclear Medicine,
University of Iowa Hospitals & Clinics
Chief, Diagnostic Imaging Services,
Iowa City VA Medical Center
Learning Objectives:
1. Discuss the current updates on targeted radiomoleclar therapy in the US.
2. Review the development of Peptide Receptor Radionuclide Therapy (PRRT).
3. Evaluate the current state of PRRT in Neuroendocrine Tumors (NETs) in the US and future direction/implications.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个